E. Tortoli, L. Rindi, A. Bartoloni, C. Garzelli, V. Manfrin, A

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

E. Tortoli, A. Bartoloni, C. Garzelli, N. Lari, F. Lavinia, A

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Molecular evolution of Mycobacterium tuberculosis

E. Tortoli, A. Bartoloni, C. Garzelli, N. Lari, F. Lavinia, A

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Evidence of transmission of verocytotoxin-producing Escherichia coli O111 from a cattle stable to a child E. Møller Nielsen, C. Jensen, D. Lau Baggesen

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.

Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland M. Eklund, M. Bielaszewska, U.-M. Nakari,

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

E. Cambau, M. Drancourt Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Non-antibiotic strategies for sepsis

Impact of immigration on tuberculosis in a low-incidence area of Italy: a molecular epidemiological approach C. Garzelli, N. Lari, B. Cuccu, E. Tortoli,

Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.

Escherichia coli native valve endocarditis

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

E. Tortoli, P. G. Rogasi, E. Fantoni, C. Beltrami, A. De Francisci, A

Sofie Arens, Jan Verhaegen, Ludo Verbist

Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,

Training for the infectious diseases speciality in Norway

M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow, L.M. Baddour

Epidemiology of opportunistic infections in AIDS patients

B. Gordts Clinical Microbiology and Infection

Levofloxacin in the treatment of ventilator-associated pneumonia

Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region K.B. Laupland, D.B. Gregson, D.L. Church,

Metagenomics and probiotics

L. Vogel, E. van Oorschot, H.M.E. Maas, B. Minderhoud, L. Dijkshoorn

Hepatitis B and C virus-related carcinogenesis

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China Y. Luo, Y. Wang, L. Ye, J. Yang Clinical.

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

C. Gagliotti, L. Nobilio, M.L. Moro

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

I. Bitar, A. Piazza Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Isolation of a novel sequevar of Mycobacterium flavescens from the synovial fluid of an AIDS patient E. Tortoli, L. Rindi, A. Bartoloni, C. Garzelli, V. Manfrin, A. Mantella, P. Piccoli, C. Scarparo Clinical Microbiology and Infection Volume 10, Issue 11, Pages 1017-1019 (November 2004) DOI: 10.1111/j.1469-0961.2004.00947.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Alignment of 16S rDNA, including the hypervariable region A, from FI-28796, Mycobacterium flavescens, Mycobacterium brumae and Mycobacterium goodii, commencing with position corresponding to base 118 on the Escherichia coli 16S rDNA. sqv., sequevar. Clinical Microbiology and Infection 2004 10, 1017-1019DOI: (10.1111/j.1469-0961.2004.00947.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Representative HPLC patterns of FI-28796, Mycobacterium flavescens, Mycobacterium brumae and Mycobacterium goodii. LMMIS, low molecular mass internal standard; HMMIS, high molecular mass internal standard. Clinical Microbiology and Infection 2004 10, 1017-1019DOI: (10.1111/j.1469-0961.2004.00947.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions